Factors influencing the willingness of US women to vaccinate their daughters against the human papillomavirus to prevent cervical cancer

Lai, Jennifer; Tinker, Anna; Cheung, Winson
June 2013
Medical Oncology;Jun2013, Vol. 30 Issue 2, p1
Academic Journal
No abstract available.


Related Articles

  • Mothers' knowledge, health beliefs and intentions to vaccinate their daughters against human papillomavirus in Korea. Kim, Jin-Sun; Kang, Hee-Young // Contemporary Nurse: A Journal for the Australian Nursing Profess;Apr/Jun2014, Vol. 47 Issue 1-2, p97 

    This study aimed to identify the factors influencing Korean mothers' intentions to vaccinate their daughters against human papillomavirus (HPV). In Korea, a mother's will is a key determinant for daughters receiving the cervical cancer vaccine. The factors influencing mothers' intentions to...

  • The Shot that Fights Cancer. Smith, Fran // Prevention;Oct2006, Vol. 58 Issue 10, p129 

    The article looks at the vaccine Gardasil, made by Merck & Co., which has been approved by the U.S. Food and Drug Administration to protect against cervical cancer and prevent genital warts. The vaccine had been found to be effective in preventing infection by the two strains of human...

  • HPV Awareness and Vaccine Acceptability in Hispanic Women Living Along the US-Mexico Border. Molokwu, Jennifer; Fernandez, Norma; Martin, Charmaine // Journal of Immigrant & Minority Health;Jun2014, Vol. 16 Issue 3, p540 

    Despite advances in prevention of cervical cancer in the US, women of Hispanic origin still bear an unequal burden in cervical cancer incidence, morbidity and mortality. Our objective was to determine the HPV vaccine knowledge and acceptability in a group of mostly Hispanic females. In this...

  • Effects of Information Framing on Human Papillomavirus Vaccination. Leader, Amy E.; Weiner, Judith L.; Kelly, Bridget J.; Hornik, Robert C.; Cappella, Joseph N. // Journal of Women's Health (15409996);Feb2009, Vol. 18 Issue 2, p225 

    Background: In June 2006, the first vaccine to prevent human papillomavirus (HPV) transmission was approved for use in females in the United States. Because the vaccine was approved for females as young as 9, its success depends on parents' and individuals' willingness to accept vaccination....

  • Disposición de los padres a pagar por una vacuna contra el virus del papiloma humano para sus hijas adolescentes. Región del Maule, Chile. Cerda, Arcadio A.; García, Leidy Y.; Albornoz, Daniela V. // Salud Pública de México;ene/feb2014, Vol. 56 Issue 1, p48 

    Objective. To determine the willingness to pay of parents of teenage daughters for a vaccine against human papillomavirus in the Maule Region, Chile. Materials and methods. A sample of 386 parents with daughters between 12 and 18 years old, representing the five largest cities of the Region of...

  • New CDC recommendations for HPV vaccine.  // Contemporary OB/GYN;Aug2006, Vol. 51 Issue 8, p21 

    The article focuses on the approval by the U.S. Food and Drug Administration of Gardasil, the first vaccine developed to protect women against cervical cancer. The vaccine, which was developed by Merck & Co., is highly effective against four types of human papillomavirus, two of which can cause...

  • Determinants of Acceptance and Subsequent Uptake of the HPV Vaccine in a Cohort in Eldoret, Kenya. Vermandere, Heleen; Naanyu, Violet; Mabeya, Hillary; Vanden Broeck, Davy; Michielsen, Kristien; Degomme, Olivier // PLoS ONE;Oct2014, Vol. 9 Issue 10, p1 

    The development of Human Papillomavirus (HPV) vaccines provides new opportunities in the fight against cervical cancer. Many acceptability studies have revealed high interest in these vaccines, but acceptance is only a precursor of behavior, and many factors, at personal, community and provider...

  • HPV vaccines less effective for Black women. Hunt, Jazelle // Michigan Citizen;11/24/2013, Vol. 36 Issue 3, pA11 

    The article reports on the results of a study which found that human papillomavirus (HPV) vaccination is less effective in preventing cervical cancer in African American women.

  • STDs SCARIER THAN CANCER FOR TEENAGERS.  // USA Today Magazine;Jul2013, Vol. 142 Issue 2818, p8 

    The article discusses a study which examined the use of human papillomavirus (HPV) vaccine in preventing cervical cancer and sexually transmitted diseases (STD) in women.

  • HPV VACCINE PROTECTS WOMEN EVEN LONGER.  // International Perspectives on Sexual & Reproductive Health;Mar2010, Vol. 36 Issue 1, p4 

    The article discusses the statistical results of an international study on the effectiveness of a vaccine used to prevent two types of human papillomavirus (HPV) that commonly lead to cervical cancer in women.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics